Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.

Clin Transl Sci · 2025 · PMC12680786 · PMID 41351276

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Improvements in lipids, in the current study, generally occurred around day 15 to day 29 and showed a trend of returning to baseline by day 36.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.